United Kingdom · Series A startup

Who invested in Re-Vana Therapeutics

One round we have observed, with the 5 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Healthcare

Funding summaryUpdated 26 Oct 2026

$12Mraised across 1 round since 2022, from 2 sources

Latest round
Series A, $12MNov 2022
Led by
Visionary Ventures
Investors
5 (1 led)
See who backed them

The rounds

  1. Nov 2022

Everyone who backed them

Visionary VenturesVC firm1round, led 1
MassChallengeAccelerator1round
SyndicateRoomVC firm1round
Techstart VenturesVC firm1round
ExSight VenturesVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Re-Vana Therapeutics

Who invested in Re-Vana Therapeutics?

Re-Vana Therapeutics's investors include Visionary Ventures, MassChallenge, SyndicateRoom, Techstart Ventures and ExSight Ventures. Visionary Ventures led its latest round.

How much has Re-Vana Therapeutics raised?

Re-Vana Therapeutics has raised $12M across 1 round since 2022.

When did Re-Vana Therapeutics last raise?

Re-Vana Therapeutics's most recent round was a Series A of $12M in Nov 2022, led by Visionary Ventures.

What was Re-Vana Therapeutics's biggest round?

Its most recent round, $12M in Nov 2022, is also its largest on record.

Who backed Re-Vana Therapeutics first?

Re-Vana Therapeutics's first round on record, in Nov 2022, was backed by Visionary Ventures, MassChallenge and SyndicateRoom and 2 others.

What stage is Re-Vana Therapeutics at?

Re-Vana Therapeutics's latest named round is a Series A, in Nov 2022.

Where is Re-Vana Therapeutics based?

Re-Vana Therapeutics is based in the United Kingdom.

Who led Re-Vana Therapeutics's rounds?

Visionary Ventures led the Series A in 2022.

Companies like Re-Vana Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.